Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 775 of 3546 entries
View as:

A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02446483 Org: User:
Start: 03/19/14 End: 03/26/14 Due: 03/26/15

A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease

Phase: N/A Priority: Normal
NCT ID: NCT06413511 Org: User:
Start: 06/03/24 End: 09/21/26 Due: 09/21/27

A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03562195 Org: User:
Start: 08/29/18 End: 09/07/22 Due: 09/07/23

Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01938456 Org: User:
Start: 10/31/13 End: 07/31/14 Due: 07/31/15

Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis

Phase: N/A Priority: Normal
NCT ID: NCT01018030 Org: User:
Start: 01/06/10 End: 07/16/10 Due: 07/16/11

GSK239512 DDI Study

Phase: N/A Priority: Normal
NCT ID: NCT01802931 Org: User:
Start: 01/07/13 End: 04/15/13 Due: 04/15/14

A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02236611 Org: User:
Start: 09/26/14 End: 06/02/15 Due: 06/02/16

A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03184987 Org: User:
Start: 06/22/17 End: 06/25/19 Due: 06/25/20

A Study to Examine the Absorption of GSK561679 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00539136 Org: User:
Start: 10/31/07 End: 03/31/08 Due: 03/31/09

Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in China

Phase: N/A Priority: Normal
NCT ID: NCT01357902 Org: User:
Start: 04/18/11 End: 05/23/11 Due: 05/23/12

Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403

Phase: N/A Priority: Normal
NCT ID: NCT00655824 Org: User:
Start: 01/01/08 End: 03/19/13 Due: 03/19/14

Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00605852 Org: User:
Start: 10/29/07 End: 05/03/08 Due: 05/03/09

Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

Phase: N/A Priority: Normal
NCT ID: NCT05630859 Org: User:
Start: 11/28/22 End: 05/23/25 Due: 05/23/26

Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea

Phase: N/A Priority: Normal
NCT ID: NCT01766206 Org: User:
Start: 03/15/13 End: 01/22/18 Due: 01/22/19

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

Phase: N/A Priority: Normal
NCT ID: NCT00382772 Org: User:
Start: 11/30/06 End: 08/31/07 Due: 08/31/08

A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01153763 Org: User:
Start: 08/09/10 End: 06/01/16 Due: 06/01/17

Effects of GSK598809 on Brain Activation in Abstinent Alcoholics

Phase: N/A Priority: Normal
NCT ID: NCT00908206 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01258530 Org: User:
Start: 12/20/10 End: 02/03/11 Due: 02/03/12

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

Phase: N/A Priority: Normal
NCT ID: NCT00478725 Org: User:
Start: 07/18/07 End: 07/01/08 Due: 07/01/09

Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)

Phase: N/A Priority: Normal
NCT ID: NCT01716533 Org: User:
Start: 02/02/13 End: 06/01/15 Due: 06/01/16

Acceptability of Hepatitis B Vaccination in General Population

Phase: N/A Priority: Normal
NCT ID: NCT01782794 Org: User:
Start: 05/31/09 End: 06/30/12 Due: 06/30/13

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00434512 Org: User:
Start: 02/20/07 End: 06/13/08 Due: 06/13/09

A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00441441 Org: User:
Start: 02/28/07 End: 01/31/08 Due: 01/31/09

Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

Phase: N/A Priority: Normal
NCT ID: NCT00240630 Org: User:
Start: 10/31/05 End: 06/30/06 Due: 06/30/07

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01640990 Org: User:
Start: 11/22/11 End: 12/09/11 Due: 12/09/12